Mannheim, Germany

Androniki Roesch


Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 207(Granted Patents)


Location History:

  • Mannheim am Oberen Luisenpark, DE (1976)
  • Mannheim, OE (1978)
  • Mannheim, DE (1976 - 1987)
  • Mannheim 1, DE (1988)

Company Filing History:


Years Active: 1976-1988

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Androniki Roesch

Introduction

Androniki Roesch is a prominent inventor based in Mannheim, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address allergic diseases. With a total of 14 patents to her name, Roesch's work has had a considerable impact on medical science.

Latest Patents

Among her latest patents are "Pyrrothine derivatives and pharmaceutical use thereof" and "Use of adenosine derivatives as anti-allergic compounds." The latter patent focuses on the use of adenosine derivatives for treating allergic diseases, as well as for managing bronchosphatic and broncho-constrictive reactions caused by inflammation. These adenosine derivatives can be utilized alone or in combination with xanthine derivatives. Additionally, her invention includes compositions that contain adenosine derivatives and optionally xanthine derivatives, along with suitable pharmaceutical carriers.

Career Highlights

Androniki Roesch is associated with Boehringer Mannheim GmbH, where she has been instrumental in advancing pharmaceutical research. Her innovative approach and dedication to her work have positioned her as a key figure in her field.

Collaborations

Throughout her career, Roesch has collaborated with notable colleagues, including Otto-Henning Wilhelms and Walter-Gunar Friebe. These partnerships have further enhanced her research and development efforts.

Conclusion

Androniki Roesch's contributions to the pharmaceutical industry through her innovative patents and collaborations highlight her importance as an inventor. Her work continues to influence the treatment of allergic diseases and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…